Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions From 2015 to 2020

被引：8

作者：

Liu, Patrick ^{[2
]}

Dhruva, Sanket S. ^{[3
,4
]}

Shah, Nilay D. ^{[5
]}

Ross, Joseph S. ^{[1
]}

机构：

[1] Yale Sch Med, Dept Internal Med, POB 208093, New Haven, CT 06520 USA

[2] Yale Sch Med, New Haven, CT USA

[3] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA USA

[4] San Francisco VA Med Ctr, San Francisco, CA USA

[5] Mayo Clin, Kern Ctr Sci Hlth Care Delivery, Div Hlth Care Policy & Res, Rochester, MN USA

来源：

JAMA NETWORK OPEN | 2021年 / 4卷 / 01期

关键词：

D O I：

10.1001/jamanetworkopen.2020.35064

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This cross-sectional study examines within-class changes in US wholesale drug prices for brand-name medications from 2015 to 2020.

引用

页数：4

共 4 条

[1]

Bureau of Labor Statistics, CONS PRIC IND CPI DA

[2] Insulin Access and Affordability Working Group: Conclusions and Recommendations [J].

Cefalu, William T. ;

Dawes, Daniel E. ;

Gavlak, Gina ;

Goldman, Dana ;

Herman, William H. ;

Van Nuys, Karen ;

Powers, Alvin C. ;

Taylor, Simeon I. ;

Yatvin, Alan L. .

DIABETES CARE, 2018, 41 (06) :1299-1311

[3] Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018 [J].

Hernandez, Inmaculada ;

San-Juan-Rodriguez, Alvaro ;

Good, Chester B. ;

Gellad, Walid F. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (09) :854-862

[4] Competition and price among brand-name drugs in the same class: A systematic review of the evidence [J].

Sarpatwari, Ameet ;

DiBello, Jonathan ;

Zakarian, Marie ;

Najafzadeh, Mehdi ;

Kesselheim, Aaron S. .

PLOS MEDICINE, 2019, 16 (07)

← 1 →